Photodynamic therapy: A new concept in medical treatment

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 8, 2000, Pages 869-880

  Sibata, C H ^a   Colussi, V C ^a   Oleinick, N L ^a   Kinsella, T J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical PDT; Light delivery; Photodynamic therapy (PDT); State of art of PDT

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT;

CLINICAL PRACTICE; DOSIMETRY; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; REVIEW;

EID: 0033851073     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2000000800002     Document Type: Review

References (60)

1. Laser Medical Research Foundation. [http://209.41.253.5:80/pdt@lmrf]. Date accessed: 10 September 1999.
2. Colussi VC, Nicola EMD & Nicola JH (1996). Phototherapy, photochemotherapy and some photosensitizers (in Portuguese). Revista da Associaçāo Médica Brasileira, 42: 229-236.
3. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J & Peng Q (1998). Photodynamic therapy (Review). Journal of the National Cancer Institute, 90: 889-905.
4. McCaughan Jr JS & Williams TE (1997). Photodynamic therapy for endobronchial malignant disease: A prospective fourteen-year study. Journal of Thoracic and Cardiovascular Surgery, 114: 940-947.
5. National Cancer Institute. [http:// cancernet.nci.nih.gov]. Date accessed: 10 September 1999.
6. Colussi VC, Feyes DK & Mukhtar H (1998). Perspectives of photodynamic therapy for skin diseases. Skin Pharmacology and Applied Skin Physiology, 11: 336-346.
7. Husain D, Miller JW, Kenney AG, Michaud N, Flotte TJ & Gragoudas ES (1997). Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. Ophthalmology, 104: 1242-1250.
8. Woodburn KW, Fan Q, Kessel D, Wright M, Mody TD, Hemmi G, Magda D, Sessler JL, Dow WC, Miller RA & Young SW (1996). Phototherapy of cancer and atheromatous plaque with texaphyrins. Journal of Clinical Laser Medicine and Surgery, 14: 343-348.
9. Smetana Z, Ben-Hur E, Mendelson E, Salzberg S, Wagner P & Malik Z (1998). Herpes simplex virus proteins are damaged following photodynamic inactivation with phthalocyanines. Journal of Photochemistry and Photobiology. B, Biology, 44: 77-83.
10. Ben-Hur E, Oetjen J & Horowitz B (1997). Silicon phthalocyanine Pc 4 and red light cause apoptosis in HIV-infected cells Photochemistry and Photobiology, 65: 456-460.
11. Colussi VC, Feyes DK, Mulvihill JW, Li Y-S, Kenney ME, Elmets CA, Oleinick NL & Mukhtar H (1999). Phthalocyanine (Pc 4) photodynamic therapy of human OVCAR-3 tumors. Photochemistry and Photobiology, 69: 236-241.
12. Wilson BC (1998). Light sources for photodynamic therapy. Photodynamic Therapy News, 1: 6-8.
13. Laustriat G (1986). Molecular mechanisms of photosensitization. Biochimie, 68: 771-778.
14. Weishaupt KR, Gomer CJ & Dougherty TJ (1976). Identification of singlet oxygen as the cytotoxic agent in cancer photoinactivation of a murine tumor. Cancer Research, 36: 2326-2329.
15. Henderson BW & Dougherty TJ (1992). How does photodynamic therapy work? Photochemistry and Photobiology, 55: 145-157.
16. Peng Q, Moan J & Nesland JM (1996). Correction of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastructural Pathology, 20: 109-129.
17. Zaidi SIA, Oleinick NL, Zaim MT & Mukhtar H (1993). Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: Electron microscopic, histopathologic and biochemical evidence. Photochemistry and Photobiology, 58: 771-776.
18. Kessel D, Luo Y, Deng Y & Cang CK (1997). The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochemistry and Photobiology, 65: 422-426.
19. Chen Q, Chen H & Hetzel FW (1996). Tumor oxygenation changes post-photodynamic therapy. Photochemistry and Photobiology, 63: 128-131.
20. Taber SW, Fingar VH & Wieman TJ (1998). Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. Journal of Surgical Oncology, 68: 209-214.
21. Fritsch C, Stege H, Saalmann G, Goerz G, Ruzicka T & Krutmann J (1997). Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatology, Photoimmunology and Photomedicine, 13: 181-185.
22. van den Bergh H (1998). On the evolution of some endoscopic light delivery systems for photodynamic therapy. Endoscopy, 30: 392-407.
23. Jacques SL (1998). Light distributions from point, line and plane sources for photochemical reactions and fluorescence in turbid biological tissues. Photochemistry and Pholobiology, 67: 23-32.
24. Mourant JR, Johnson TM, Los G & Bigio IJ (1999). Non-invasive measurement of chemotherapy drug concentrations in tissue: preliminary demonstrations of in vivo measurements. Physics in Medicine and Biology, 44: 1397-1417.
25. Wagnieres G, Cheng S, Zellweger M, Utke N, Braichotte D, Ballini JP & van den Bergh H (1997). An optical phantom with tissue-like properties in the visible for use in PDT and fluorescence spectroscopy. Physics in Medicine and Biology, 42: 1415-1426.
26. Moan J & Sommer S (1985). Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Research, 45: 1608-1610.
27. 2 distribution in tumour tissue of DS-carcinoma. Oncology, 30: 475-484.
28. Tromberg BJ, Orenstein A, Kimel S, Barker SJ, Hyatt J, Nelson JS & Berns MW (1990). In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochemistry and Photobiology, 52: 375-385
29. Chen Q, Cnen H, Shapiro H & Hetzel FW (1996). Sequencing of combined hyperthermia and photodynamic therapy. Radiation Research, 146: 293-297.
30. Jirsa Jr M, Poucková P, Doleza J, Pospis I J & Jirsa M (1991) Hyperbaric oxygen and photodynamic therapy in tumor-bearing nude mice. European Journal of Cancer, 27: 109.
31. Colussi VC (1997). Intensificaçāo da terapia fotodinàmica do cáncer pela variaçāo da pressāo parcial do oxigénio no tecido: Efeitos físicos e biològicos. Doctoral thesis, University of Campinas/ UNICAMP, Sāo Paulo, Brazil.
32. Foster TH, Hartley DF, Nichols MG & Hilf R (1993). Fluence rate effects in photodynamic therapy of multicell tumor spheroids. Cancer Research, 53: 1249-1254.
33. Sitnik TM, Hampton JA & Henderson BW (1998). Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. British Journal of Cancer, 77: 1386-1394.
34. Lightdale CJ, Heier SK, Marcon NE, McCaughan Jr JS, Gerdes H, Overholt BF, Sivak Jr MV, Stiegmann GV & Nava HR (1995). Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd: YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointestinal Endoscopy, 42: 507-512.
35. Biel MA (1998). Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope, 108: 1259-1268.
36. Muller PJ & Wilson BC (1995). Photodynamic therapy for recurrent supratentorial gliomas. Seminars in Surgical Oncology, 11: 346-354.
37. Popovic E, Kaye A & Hill J (1996). Photodynamic therapy of brain tumors. Journal of Clincal Laser Medicine and Surgery, 14: 251-256.
38. Takita H & Dougherty TJ (1995). Intracavitary photodynamic therapy for malignant pleural mesothelioma. Seminars in Surgical Oncology, 11 368-371.
39. DeLaney TF, Sindelar WF, Tochner Z, Smith PD, Friauf WS, Thomas G, Dachowski L, Cole JW, Steinberg SM & Glatstein E (1993). Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. International Journal of Radiation Oncology, Biology, Physics, 25: 445-457.
40. Kennedy JC, Marcus SL & Pottier RH (1996). Photodynamic therapy (PDT) and photodiagnogis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. Journal of Clinical Laser Medicine and Surgery. 14: 289-304.
41. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE & Nesland JM (1997). 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer, 79: 2282-2308.
42. Husain D, Miller JW, Michaud N, Connolly E, Flotte TJ & Gragoudas ES (1996). Intravenous infusion of liposomal benzoporphyrin derivative for protodynamic therapy of experimental choroidal neovascularization. Archives of Ophthalmology, 114: 978-985.
43. Allison BA, Crespo MT, Jam AK, Richter AM, Hsiang YN & Levy JG (1997). Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits. Photochemistry and Photobiology, 65: 877-883.
44. Taylor CR, Kwangsukstith C, Wimberly J, Kollias N & Anderson RR (1999). Turbo-PUVA: dihydroxyacetone-enhanced photochemotherapy for psoriasis: a pilot study. Archives of Dermatology, 135: 540-544.
45. Tanew A, Radakovic-Fijan S, Schemper M & Honigsmann H (1999). Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. Archives of Dermatology, 135: 519-524.
46. Woodburn KW, Fan Q, Kessel D, Luo Y & Young SW (1998). Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. Journal of Investigative Dermatology, 110: 746-751.
47. Razum N, Snyder A & Doiron D (1996). SnEt2: Clinical update Proceedings of SPIE (Society for Photo-optical International Engineering), 2675: 43-46.
48. Grosjean PSJ & Wagnieres G (1996). Tetra (m-hydroxyphenyl) chlorin clinical photodynamic therapy of early bronchial and oesophageal cancer. Laser in Medicine Science, 11: 227-235.
49. Taber SW, Fingar VH, Coots CT & WiemanTJ (1998). Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a phase I clinical study. Clinical Cancer Research, 4: 2741-2746.
50. Oleinick NL, Antunez AR, Clay ME, Rihter BD & Kenney ME (1993). New phthalocyanine photosensitizers for photodynamic therapy. Photochemistry and Photobiology, 57: 243-247.
51. Separovic D, He J & Oleinick NL (1997). Ceramide generation in response to photodynamic treatment of L5178Y mouse lymphoma cells. Cancer Research, 57: 1717-1721.
52. Anderson CY, Freye K, Tubesing KA, Li Y-S, Kenney ME, Mukhtar H & Elmets CA (1998). A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice. Photochemistry and Photobiology, 67: 332-336.
53. Profio AE & Doiron DR (1981). Dosimetry considerations in phototherapy. Medical Physics, 8: 190-196.
54. Overholt BF, Panjehpour M & Haydek JM (1999). Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointestinal Endoscopy, 49: 1-7
55. Edell ES & Cortese DA (1992). Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest, 102: 1319-1322.
56. Kato H, Okunaka T & Shimatani H (1996) Photodynamic therapy for early stage bronchogenic carcinoma. Journal of Clinical Laser Medicine and Surgery, 14: 235-238.
57. Cortese DA, Edell ES & Kinsey JH (1997). Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clinic Proceedings, 72: 595-602.
58. Jones CM, Mang T, Cooper M, Wilson BD & Stoll Jr HL (1992). Photodynamic therapy in the treatment of Bowen's disease. Journal of the American Academy of Dermatology, 27: 979-982.
59. Berenbaum M, Bonnet R & Cheorettan E (1993). Selectivity of meso-tetra-(hydroxyphenyl) porphyrins and chlorins and photofrin in causing photodamage in tumor, skin, muscle and bladder. Lasers in Medical Science, 8: 235-243.
60. Nseyo UO, DeHaven J, Dougherty TJ, Potter WR, Merrill DL, Lundahl SL & Lamm DL (1998). Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. Journal of Clinical Laser Medicine and Surgery, 16: 61-68.